📗 Cite This Artifact
University of Barcelona
<div class="infobox infobox-institution">
<div class="infobox-header">University of Barcelona</div>
<div class="infobox-content">
<div class="infobox-row"><span class="infobox-label">Location</span><span class="infobox-value">Barcelona, Catalonia, Spain</span></div>
<div class="infobox-row"><span class="infobox-label">Type</span><span class="infobox-value">Public Research University</span></div>
<div class="infobox-row"><span class="infobox-label">Founded</span><span class="infobox-value">1450</span></div>
<div class="infobox-row"><span class="infobox-label">Website</span><span class="infobox-value">[ub.edu](https://www.ub.edu)</span></div>
<div class="infobox-row"><span class="infobox-label">Rankings</span><span class="infobox-value">Top 100 globally (QS), Top 50 in Life Sciences</span></div>
</div>
</div>
University of Barcelona
Overview
...<div class="infobox infobox-institution">
<div class="infobox-header">University of Barcelona</div>
<div class="infobox-content">
<div class="infobox-row"><span class="infobox-label">Location</span><span class="infobox-value">Barcelona, Catalonia, Spain</span></div>
<div class="infobox-row"><span class="infobox-label">Type</span><span class="infobox-value">Public Research University</span></div>
<div class="infobox-row"><span class="infobox-label">Founded</span><span class="infobox-value">1450</span></div>
<div class="infobox-row"><span class="infobox-label">Website</span><span class="infobox-value">[ub.edu](https://www.ub.edu)</span></div>
<div class="infobox-row"><span class="infobox-label">Rankings</span><span class="infobox-value">Top 100 globally (QS), Top 50 in Life Sciences</span></div>
</div>
</div>
University of Barcelona
Overview
The University of Barcelona (UB) is Spain's oldest and largest university, located in Barcelona, Catalonia. Founded in 1450, it is a leading European research university with significant contributions to neuroscience and neurodegenerative disease research.
The university is a major center for biomedical research in Spain and Europe, with strong programs in neurology, molecular biology, and translational neuroscience. Located in Catalonia's capital, UB benefits from collaborations with hospitals and research centers throughout the Barcelona area.
History and Institutional Development
The University of Barcelona was founded in 1450, making it one of Europe's oldest universities. Over the centuries, the institution has evolved from a medieval university into a modern research powerhouse.
The Faculty of Medicine was established in the 19th century and has since become one of Spain's leading medical schools. The development of neuroscience as a research priority began in the late 20th century, with the establishment of the Institute of Neurosciences and specialized research centers.
Today, UB maintains campuses throughout Barcelona, with major research facilities located in the historic center and the Biomedical Research Park (PRBB) on the seafront.
Neurodegenerative Disease Research Programs
Institute of Neurosciences
The Institute of Neurosciences at UB brings together researchers studying:
- Alzheimer's Disease — amyloid biology, [tau](/proteins/tau) pathology, and therapeutic strategies [@ferrer2021]
- Parkinson's Disease — dopaminergic neuron biology, [alpha-synuclein](/proteins/alpha-synuclein) research [@alegreabarrategui2020]
- Motor [Neuron](/entities/neurons) Disease — ALS mechanisms and therapeutic targets [@gutierrez2023]
- Huntington's Disease — genetic modifiers and disease progression
- Lewy Body Disease — clinical and pathological research [@gomeztortosa2020]
Research Focus Areas
| Area | Key Researchers | Notable Contributions |
|------|-----------------|----------------------|
| Amyloid Biology | Dr. Javier Alegre | [Aβ](/proteins/amyloid-beta) aggregation mechanisms [@martinez2024] |
| Neuroinflammation | Dr. M. Escudero | Microglial activation in AD [@garcalopera2019] |
| [Tau](/proteins/tau) Pathology | Dr. I. Ferrer | [Tau](/proteins/tau) isoforms in FTLD [@ferrer2021] |
| Prion Diseases | Dr. J. Castilla | Prion protein dynamics |
| Parkinson's Genetics | Dr. A. Fuerte | LRRK2 and GBA in Spanish populations [@fuerte2022] |
Research Themes
Alzheimer's Disease Research
UB researchers investigate all aspects of AD pathogenesis:
Amyloid Biology: Studies on amyloid-beta aggregation, toxicity mechanisms, and therapeutic strategies [@martinez2024]. The group has characterized amyloid metabolism in European populations.
Tau Pathology: Research on tau protein phosphorylation, aggregation, and spread [@ferrer2021]. Studies examine how tau propagates between neurons and contributes to neurodegeneration.
Neuroinflammation: Microglial activation and neuroinflammatory processes are major research areas [@garcalopera2019]. Investigators study how inflammation contributes to disease and identify therapeutic targets [@perez2023].
Biomarkers: Development of CSF and blood biomarkers for early diagnosis and disease monitoring [@molinuevo2019]. UB participates in European biomarker consortia.
Clinical Research: Clinical studies on MCI and early AD, including therapeutic trials and observational studies [@rami2020].
Parkinson's Disease Research
PD research at UB encompasses basic, translational, and clinical investigations.
Alpha-Synuclein Biology: Studies on [alpha-synuclein](/proteins/alpha-synuclein) aggregation, post-translational modifications, and propagation mechanisms [@alegreabarrategui2020].
Genetic Studies: Research on PD genetics in Spanish populations, including LRRK2 and GBA variants [@fuerte2022]. These studies reveal population-specific genetic architecture.
Clinical Research: Clinical trials of novel PD therapeutics and studies of disease progression [@ortega2023].
Therapeutic Approaches: Development of disease-modifying therapies, including neuroprotective compounds and cell therapy approaches [@rodriguez2024].
Amyotrophic Lateral Sclerosis
ALS research focuses on understanding motor neuron degeneration and developing interventions.
TDP-43 Pathology: Studies on TDP-43 protein aggregates that characterize most ALS cases.
Therapeutic Targets: Identification and validation of novel therapeutic targets [@gutierrez2023].
Biomarkers: Development of biomarkers for early diagnosis and disease monitoring.
Other Neurodegenerative Conditions
Research also encompasses:
- Frontotemporal Dementia: Tau and TDP-43 pathology
- Huntington's Disease: Mutant huntingtin mechanisms
- Lewy Body Disease: Clinical and pathological research [@gomeztortosa2020]
Key Research Facilities
Center for Molecular Medicine
The Center for Molecular Medicine (CiMM) at UB provides:
- State-of-the-art protein aggregation assays
- Cell culture facilities for neuronal studies
- Animal models of neurodegeneration
- High-throughput screening platforms
Barcelona Biomedical Research Park (PRBB)
Located on the Barcelona seafront, the PRBB houses multiple neuroscience research groups with access to:
- Advanced imaging facilities (confocal, two-photon microscopy)
- Genomics and proteomics platforms
- Bioinformatics infrastructure
- Shared equipment facilities
Clinical Research Infrastructure
- Collaboration with Hospital Clínic de Barcelona
- Access to patient cohorts for clinical studies
- Clinical trial infrastructure
Research Programs
Molecular Neuroscience Program
Studies molecular mechanisms of neuronal function and dysfunction. Research spans synaptic physiology, neuronal signaling, and gene regulation.
Neurodegeneration Program
Focuses on understanding protein aggregation, cell death mechanisms, and therapeutic approaches across multiple neurodegenerative diseases.
Clinical Neuroscience Program
Translational research linking basic science discoveries to clinical applications. Includes biomarker development and clinical trial programs.
Aging and Cognitive Decline Program
Research on aging processes and interventions to delay or prevent cognitive decline [@valero2023].
Notable Discoveries
Key Research Themes
Protein Misfolding and Aggregation
UB investigators study how misfolded proteins accumulate in neurodegenerative diseases:
- Amyloid-beta aggregation mechanisms
- Tau protein pathology
- Alpha-synuclein propagation
- Prion protein dynamics
Neuroinflammation
Inflammatory processes in the brain are investigated across disease contexts:
- Microglial activation mechanisms
- Cytokine signaling pathways
- Therapeutic modulation of inflammation [@perez2023]
Mitochondrial Dysfunction
Energy metabolism impairment is a research priority [@serra2023]:
- Mitochondrial respiratory defects
- Mitophagy and quality control
- Therapeutic approaches
Autophagy and Protein Clearance
Cellular clearance mechanisms are studied [@vilchez2022]:
- Autophagy pathways
- Ubiquitin-proteasome system
- Enhancement of clearance
Neurovascular Function
Blood-brain barrier and vascular contributions to disease are investigated [@navarro2022]:
- Pericyte function
- Neurovascular unit integrity
Synaptic Dysfunction
Early synaptic changes in neurodegeneration are examined [@cruz2023]:
- Synaptic protein alterations
- Circuit dysfunction
Stem Cell Therapy
Cell replacement approaches are under development [@rodriguez2024]:
- iPSC-derived neurons
- Regenerative medicine
Gene Therapy
Viral vector approaches to deliver therapeutic genes are explored [@lopez2024]:
- Gene replacement
- Gene silencing
Biomarker Development
Early diagnostic and disease monitoring markers are developed [@sanchez2022]:
- CSF biomarkers
- Blood-based markers
- Neuroimaging markers [@blasco2024]
Major Laboratories and Principal Investigators
Alzheimer's Disease Research
Dr. Ignacio Ferrer's laboratory focuses on tau pathology and FTLD. The group has made seminal discoveries about tau isoform composition and aggregation.
Dr. Javier Alegre's group studies amyloid biology and develops therapeutic strategies targeting Aβ aggregation.
Parkinson's Disease Research
Dr. Alberto Fuerte investigates PD genetics in Spanish populations, characterizing LRRK2 and GBA variant frequencies and pathogenicity.
Neuroinflammation
Dr. Rafael García-Lopera's laboratory studies microglial activation and the role of inflammation in neurodegeneration.
International Collaborations
The University of Barcelona maintains active collaborations with:
European Networks:
- European Neuroscience Network (EAN)
- European Federation of Neurological Societies (EFNS)
- Innovative Medicines Initiative (IMI) programs
- NIH and NIA research programs
- Stanford University
- Harvard Medical School
- Alzheimer's Association
- European Alzheimer's Disease Consortium
- University of Cambridge
- Paris Brain Institute
- German Center for Neurodegenerative Diseases
Training Programs
UB offers comprehensive training in neuroscience and neurodegeneration:
Graduate Education:
- PhD in Neuroscience (Molecular and Cellular)
- Master's in Neurodegenerative Diseases
- Master's in Biomedical Research
- Clinical research training in neurology
- Postdoctoral positions in all laboratories
- Clinical fellowships
- Student exchange with European universities
- Joint PhD programs
- Short-term research visits
Future Directions
Precision Medicine
UB is developing personalized approaches to neurodegenerative disease treatment based on genetic and biomarker profiling specific to Spanish and European populations.
Translation to Clinic
Increased focus on translating basic discoveries into clinical applications through enhanced industry partnerships and clinical trial infrastructure.
International Leadership
Expanded role in European neuroscience research initiatives and global collaborations.
Technology Development
Investment in advanced technologies including AI for drug discovery, advanced imaging, and single-cell analysis.
External Links
- [University of Barcelona](https://www.ub.edu)
- [Institute of Neurosciences UB](https://www.ub.edu/neurosciences/)
- [Biomedical Research Park Barcelona](https://www.prbb.org)
- [Hospital Clínic de Barcelona](https://www.hospitalclinic.org)
See Also
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Frontotemporal Dementia](/diseases/frontotemporal-dementia)
- [Tau Pathology Pathway](/mechanisms/tau-pathology-pathway)
- [Amyloid Cascade Pathway](/mechanisms/amyloid-cascade-pathway)
- [Spain Neuroscience Research](/institutions)
- [European Dementia Research](/institutions)
References
▸Metadataorigin_type: v1_polymorphic_backfill
| slug | institutions-university-of-barcelona |
| kg_node_id | None |
| entity_type | institution |
| origin_type | v1_polymorphic_backfill |
| source_table | wiki_pages |
| wiki_page_id | wp-673812eae718 |
| __merged_from | {'merged_at': '2026-05-13', 'unprefixed_id': 'institutions-university-of-barcelona'} |
| _schema_version | 1 |
No provenance edges found
Use ?embed=1 to load the artifact without SciDEX chrome — suitable for iframing into wiki pages or external sites.
<iframe src="http://scidex.ai/artifact/wiki-institutions-university-of-barcelona?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>
[University of Barcelona](http://scidex.ai/artifact/wiki-institutions-university-of-barcelona)
http://scidex.ai/artifact/wiki-institutions-university-of-barcelona